Coronavirus: Dolly Parton donates $1m for cure research
Vanderbilt University is looking into antibody therapies for Covid-19
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Dolly Parton has announced she’s donating $1m to research looking for a cure to coronavirus.
The artist made the announcement on social media on Wednesday.
“My longtime friend Dr Naji Abumrad, who’s been involved in research at Vanderbilt for many years, informed me that they were making some exciting advancements towards research of the coronavirus for a cure,” she tweeted.
“I am making a donation of $1 million to Vanderbilt towards that research and to encourage people that can afford it to make donations.”
Dr Naji Abumrad is a surgeon at Vanderbilt University Medical Center in Nashville, Tennessee, where Parton rose to fame.
The medical centre announced on 23 March that it has started researching antibody therapies for Covid-19.
Researchers are analysing antibodies isolated from the blood of people who have recovered from Covid-19, looking to see if those antibodies can inhibit the virus and possibly stop it from causing illness, according to the centre.
Dr James Crowe, director of the Vanderbilt Vaccine Center, said the team hopes to “prepare antibodies for human clinical trials by this summer”.
“We have ultra-rapid antibody discovery technologies and already have discovered SARS-CoV-2 antibodies,” Crowe added.
“Our partners have the manufacturing and product development expertise to turn these antibodies into effective biological drugs very quickly.”
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments